Novozymes Biopharma initiates production of hyaluronic acid
Novozymes’ hyaluronic acid is presently being sold to medical device and pharma customers. Novozymes executive vice president Thomas Videbæk said the shipment of first commercial hyaluronic acid material
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.